CellSource , Ltd.'s inventory is $320M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (July 2026), 4880.T shows a inventory of $320M. That compares with $290M in the prior-year period — up 11.9% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 4880.T's inventory is now $320M (was $290M) — a 11.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CellSource , Ltd. is outperforming or lagging.
Tracking 4880.T's inventory over time shows whether CellSource , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $320M That compares with $290M in the prior-year period — up 11.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this inventory page, Stockcircle has CellSource , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $320M) with ownership activity and broader fundamentals.
CellSource , Ltd.'s inventory is $320M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.